Skip to search formSkip to main contentSkip to account menu

Neuromuscular Nondepolarizing Agents

Known as: Drugs, Curariform, Neuromuscular Blocking Agents, Competitive, Muscle Relaxants, Non Depolarizing 
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Background:Residual postoperative paralysis from nondepolarizing neuromuscular blocking agents (NMBAs) is a known problem. This… 
Review
2014
Review
2014
BACKGROUND:Although experts agree on the importance of quantitative neuromuscular blockade monitoring, particularly for managing… 
Review
2011
Review
2011
  • B. ThongT. Tan
  • British Journal of Clinical Pharmacology
  • 2011
  • Corpus ID: 27531339
The aim of this review was to describe the current evidence-based knowledge of the epidemiology, prevalence, incidence, risk… 
Review
2010
Review
2010
The changing opinion regarding some of the traditional components of rapid sequence induction and intubation (RSII) creates wide… 
Review
2006
Review
2006
Lethal hyperkalemic response to succinylcholine continues to be reported, but the molecular mechanisms for the hyperkalemia have… 
Review
2001
Review
2001
BACKGROUND AND OBJECTIVE Factors which lead to prolonged stay in the day-care unit and unplanned admission after day-case surgery… 
Highly Cited
1992
Highly Cited
1992
ORG-9426 is a new steroidal nondepolarizing neuromuscular blocking drug. We determined the dose-response relationship of ORG-9426… 
Highly Cited
1968
Highly Cited
1968
1. Summit metabolism of lambs declined steadily from about 3·5 l. O2/kg.hr during the first day of life, to about 2·0 l. O2/kg.hr…